CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banerjee, D.
Right arrow Articles by Bertino, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banerjee, D.
Right arrow Articles by Bertino, J. R.

Cell Growth & Differentiation, Vol 6, Issue 11 1405-1413, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress

D Banerjee, HJ Lenz, B Schnieders, DJ Manno, JF Ju, CP Spears, D Hochhauser, K Danenberg, P Danenberg and JR Bertino
Molecular Pharmacology and Therapeutics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.

HL60 cells, which lack the p53 gene due to a deletion, were used as an in vitro model system to study the effect of wild-type p53 gene expression on hematopoietic differentiation. We transfected HL60 cells with wild-type p53 and two mutant p53 cDNAs encoding the Val to Ala mutation at codon 143 and the Arg to Trp mutation at codon 248. Flow cytometry, growth, and cytochemical analysis for alpha-napthyl butyrate esterase activity and nitroblue tetrazolium reduction indicated that wild-type p53 but not mutant p53 induced early monocytic differentiation in the transfected HL60 cells without terminal growth arrest. The wild-type p53 transfectants did not differentiate along the granulocytic pathway, even when induced with 1.25% DMSO for 6 days; rather, these cells resembled monocytic cells, confirming that wild-type p53 transfection caused these cells to become committed to differentiate along the monocytic pathway. HL60 cells transfected with wild-type p53 were more sensitive to stress, such as growth in serum-depleted medium and exposure to a chemotherapeutic agent, etoposide.


This article has been cited by other articles:


Home page
J Biol ChemHome page
P. G. Fuhrken, P. A. Apostolidis, S. Lindsey, W. M. Miller, and E. T. Papoutsakis
Tumor Suppressor Protein p53 Regulates Megakaryocytic Polyploidization and Apoptosis
J. Biol. Chem., June 6, 2008; 283(23): 15589 - 15600.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. L. Kathrein, R. Lorenz, A. M. Innes, E. Griffiths, and S. Winandy
Ikaros Induces Quiescence and T-Cell Differentiation in a Leukemia Cell Line
Mol. Cell. Biol., March 1, 2005; 25(5): 1645 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Heffeter, M. Pongratz, E. Steiner, P. Chiba, M. A. Jakupec, L. Elbling, B. Marian, W. Korner, F. Sevelda, M. Micksche, et al.
Intrinsic and Acquired Forms of Resistance against the Anticancer Ruthenium Compound KP1019 [Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A)
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 281 - 289.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. V. Gaitonde, W. Qi, R. R. Falsey, N. Sidell, and J. D. Martinez
Morphologic Conversion of a Neuroblastoma-derived Cell Line by E6-mediated p53 Degradation
Cell Growth Differ., January 1, 2001; 12(1): 19 - 27.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
K. Chylicki, M. Ehinger, H. Svedberg, and U. Gullberg
Characterization of the Molecular Mechanisms for p53-mediated Differentiation
Cell Growth Differ., November 1, 2000; 11(11): 561 - 571.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
K. Chylicki, M. Ehinger, H. Svedberg, G. Bergh, I. Olsson, and U. Gullberg
p53-mediated Differentiation of the Erythroleukemia Cell Line K562
Cell Growth Differ., June 1, 2000; 11(6): 315 - 324.
[Abstract] [Full Text]


Home page
BloodHome page
L. A. Porter, G. Singh, and J. M. Lee
Abundance of cyclin B1 regulates gamma -radiation-induced apoptosis
Blood, April 15, 2000; 95(8): 2645 - 2650.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. K. Reddy, J. Lu, and A. S. Lee
The Endoplasmic Reticulum Chaperone Glycoprotein GRP94 with Ca2+-binding and Antiapoptotic Properties Is a Novel Proteolytic Target of Calpain during Etoposide-induced Apoptosis
J. Biol. Chem., October 1, 1999; 274(40): 28476 - 28483.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Maki, K. Mitani, T. Yamagata, M. Kurokawa, Y. Kanda, Y. Yazaki, and H. Hirai
Transcriptional Inhibition of p53 by the MLL/MEN Chimeric Protein Found in Myeloid Leukemia
Blood, May 15, 1999; 93(10): 3216 - 3224.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Tentori, P. M. Lacal, E. Benincasa, D. Franco, I. Faraoni, E. Bonmassar, and G. Graziani
Role of Wild-Type p53 on the Antineoplastic Activity of Temozolomide Alone or Combined with Inhibitors of Poly(ADP-Ribose) Polymerase
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 884 - 893.
[Abstract] [Full Text]


Home page
BloodHome page
P. Wlodarski, M. Wasik, M. Z. Ratajczak, C. Sevignani, G. Hoser, J. Kawiak, A. M. Gewirtz, B. Calabretta, and T. Skorski
Role of p53 in Hematopoietic Recovery After Cytotoxic Treatment
Blood, April 15, 1998; 91(8): 2998 - 3006.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
K. Sabapathy, M. Klemm, R. Jaenisch, and E. F. Wagner
Regulation of ES cell differentiation by functional and conformational modulation of p53
EMBO J., October 15, 1997; 16(20): 6217 - 6229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.